Ovid Therapeutics to Present at Upcoming August Investor Conferences
July 30 2024 - 7:00AM
Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company
dedicated to meaningfully improving the lives of people affected by
certain epilepsies and brain conditions, today announced that
management will participate in two upcoming investor conferences in
August:
- BTIG Virtual Biotechnology
Conference – Ovid will participate in a fireside chat on Tuesday,
August 6th at 10:00 a.m. ET.
- 2024 Wedbush PacGrow
Healthcare Conference – Ovid will participate in a panel discussion
on Tuesday, August 13th at 10:15 a.m. ET.
Live webcasts of the fireside chat and panel
discussion can be accessed through the Events & Presentations
section of the Company’s website at investors.ovidrx.com. An
archived replay of the webcast will be available on the Company’s
website following the live presentation.
About Ovid Therapeutics
Ovid Therapeutics Inc. is a New York-based
biopharmaceutical company that is dedicated to improving the lives
of people affected by certain epilepsies and brain conditions with
seizure symptoms. The Company is advancing a pipeline of novel,
targeted small molecule candidates that modulate the intrinsic and
extrinsic factors involved in neuronal hyperexcitability causative
of seizures and other neurological symptoms. Ovid is developing:
OV888/GV101 capsule, a potent and highly selective ROCK2 inhibitor
capsule, for the potential treatment of cerebral cavernous
malformations and other rare central nervous system diseases;
OV329, a GABA-aminotransferase inhibitor, a potential therapy for
treatment-resistant seizures; and OV350, a direct activator of the
KCC2 transporter, for the potential treatment of epilepsies and
other psychiatric conditions. For more information about these and
other Ovid research programs, please visit www.ovidrx.com.
Contacts
Investor Relations:Garret
Bonney617-735-6093IR@ovidrx.com
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Sep 2023 to Sep 2024